Back to results
US 2010/0143296 A1Published application
Podophyllotoxin inhibitors of topoisomerase ii
AssigneeAuspex Pharmaceuticals, Inc.
InventorThomas G. Gant
Life of this patent
Estimating the term…
Abstract
The present invention relates to new podophyllotoxin inhibitors of topoisomerase II, pharmaceutical compositions thereof, and methods of use thereof.
Claims47
A compound of structural Formula I
- or a pharmaceutically acceptable salt thereof, wherein:
- R1 is selected from the group consisting of hydrogen, deuterium, —P(O)(OH)2, —P(O)(OD)OH, and —P(O)(OD)2;
- R2-R3 are independently selected from the group consisting of —CH3, —CH2D, —CHD2, and —CD3;
- R4-R25 and R27-R29 are independently selected from the group consisting of hydrogen and deuterium;
- R26 is selected from the group consisting of —CH3, —CH2D, —CD3, and
- and
- at least one of R1-R29 is deuterium or contains deuterium.
4 more elements
Dependencies are inferred from the claim text.